Source comparison
Best CJC-1295 No DAC & Ipamorelin for Muscle Growth: Stack Comparison
Below is a comparison of peptide stack configurations used in muscle growth research, evaluating synergy, administration complexity, and observed IGF-1 response based on published trials and clinical observations. CJC-1295 no DAC + Ipamorelin GHRH analogue + s
This comparison does not assign a generated winner or score.
- Below is a comparison of peptide stack configurations used in muscle growth research, evaluating synergy, administration complexity, and observed IGF-1 response based on published trials and clinical observations.
- CJC-1295 no DAC + Ipamorelin
- GHRH analogue + selective ghrelin agonist; dual-pathway GH pulse
- 100–200 mcg each, 2–3x daily
- 1.5–2.0x baseline at 2–4 weeks
- Moderate (requires multiple daily injections)
- Gold standard for research; pulsatile GH mimics physiology, minimal cortisol/prolactin spike, synergistic IGF-1 response
- CJC-1295 with DAC + Ipamorelin
- Extended half-life GHRH analogue + ghrelin agonist; sustained GH elevation
- 200–600 mcg CJC-DAC weekly + 200 mcg Ipamorelin 2x daily
- 1.8–2.5x baseline, sustained
- Low (weekly CJC injection, daily Ipamorelin)
- Convenient but risks receptor desensitization; sustained supraphysiological GH disrupts natural pulsatility
- Ipamorelin + GHRP-2
- Dual ghrelin receptor agonists; amplified GH pulse
- 2.0–2.8x baseline (higher peak, shorter duration)
- Moderate
- Produces larger GH spikes but GHRP-2 elevates cortisol/prolactin 20–40%; not ideal for long-term use
- Sermorelin + Ipamorelin
- GHRH analogue + ghrelin agonist; similar to CJC no DAC but shorter half-life
- 200–300 mcg each, 2–3x daily
- 1.3–1.8x baseline
- Effective but Sermorelin's 5–10 minute half-life requires precise timing; CJC-1295 no DAC offers superior convenience
- CJC-1295 no DAC + GHRP-6
- GHRH analogue + non-selective ghrelin agonist
- 1.8–2.3x baseline
- GHRP-6 stimulates appetite (ghrelin mimetic), useful for bulking phases but causes water retention and cortisol elevation
- Standalone CJC-1295 no DAC
- GHRH analogue only; single-pathway GH stimulation
- 200–300 mcg, 2–3x daily
- 1.2–1.5x baseline
- Low
- Modest IGF-1 response; less effective than combinations; useful as a budget or minimalist approach